What an amazing #AHA24 with a great team! Jenna wins the gold!
www.biorxiv.org/content/10.1.... Our attempt to understand myopathy and exercise intolerance in PAH in greater detail.
www.jci.org/articles/vie.... Now out in @jci.org, estrogen exerts cardio protective effects via microtubule modulation!
www.jci.org/articles/vie.... Our attempt to take in end-organ dysfunction with the liver as our focus in PAH/RV Failure. @jci.org @natrevgastrohep.nature.com @the-asci.org @mark-toshner.bsky.social
Our latest attack on RV failure is out! www.ahajournals.org/doi/10.1161/...
www.ahajournals.org/doi/10.1161/.... Our most recent work attacking RV failure! @mark-toshner.bsky.social @ahascience.bsky.social @ahajournals.bsky.social
I was so impressed by the beauty of the Duke campus!
Husband, father, physician-scientists who loves metabolism, cytoskeleton, inflammation, and organ crosstalk
Kurt
😁Congratulations to Stephen L. Archer, MD, recipient of the PC Robert F. Grover Award! @ats-pc.bsky.social This prestigious recognition honors outstanding contributions to pulmonary vascular disease research and innovation.
@drstephenarcher.bsky.social Learn more: site.thoracic.org/assemblies/p...
Background: Pulmonary arterial hypertension (PAH) is a rare but debilitating condition that causes exercise intolerance and ultimately death. Skeletal muscle derangements contribute to depressed exerc...
BACKGROUND: Right ventricular (RV) dysfunction is a risk factor for death in multiple cardiovascular
diseases, but RV-enhancing therapies are lacking. Inhibition of GP130 (glycoprotein-130)
signaling ...
BACKGROUND: Inflammation suppresses right ventricular (RV) function in pulmonary arterial hypertension
(PAH). In particular, we showed GP130 (glycoprotein-130) signaling promotes pathological
microtub...
